<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01437761</url>
  </required_header>
  <id_info>
    <org_study_id>150-11</org_study_id>
    <nct_id>NCT01437761</nct_id>
  </id_info>
  <brief_title>Sorbent Treatment Prescriptions Pilot Study</brief_title>
  <acronym>Sorb2</acronym>
  <official_title>Hemodialysis With the 2008 Sorbent System: A Pilot Evaluation of Different Treatment Prescriptions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Renal Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Renal Solutions, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Renal Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare how well blood of renal failure patients is cleaned with the new 2008&#xD;
      Sorbent System using two different dialysate speeds.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The &quot;2008 Sorbent System&quot; is a new type of hemodialysis machine that requires only about 2&#xD;
      gallons of dialysate for a treatment because it can turn used dialysate into fresh dialysate&#xD;
      again by filtering it through a special cleaning cartridge (called a &quot;sorbent&quot;). This new&#xD;
      machine is approved by the U.S. Food and Drug Administration to clean the blood of patients&#xD;
      whose kidneys have failed.&#xD;
&#xD;
      This study will compare the degree of blood cleansing achieved with the new 2008 Sorbent&#xD;
      System using two different speeds at which the dialysate runs through the dialysis machine.&#xD;
      This will tell us if the faster speed really does provide better cleaning (and how much) with&#xD;
      this new machine.&#xD;
&#xD;
      How well the blood of a patient is cleaned by this procedure is determined by several&#xD;
      factors. For example, longer treatment times generally provide better blood cleansing. Higher&#xD;
      speeds at which the cleaning fluid runs through the artificial kidney do, too.&#xD;
&#xD;
      Since the 2008 Sorbent System is a new machine (and in some ways different from standard&#xD;
      hemodialysis machines), other aspects may be different, too, between the 2008 Sorbent System&#xD;
      and regular hemodialysis machines. Specifically, this study looks at how well this new&#xD;
      machine corrects the patients' acid-base status (a common requirement in these patients),&#xD;
      what effect the treatment has on inflammation in the patients' blood, how the levels of&#xD;
      important substances in the blood are influenced (acetate, sulfate, nitrate, carbon dioxide),&#xD;
      and if cleaning fluid in the 2008 Sorbent System contains any substances that are not found&#xD;
      in the cleaning fluid used by regular hemodialysis machines.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Change of Institutional Affliation &amp; Funding Changes&#xD;
  </why_stopped>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment Adequacy</measure>
    <time_frame>4 weeks</time_frame>
    <description>spKt/V, eKt/V, and Std Weekly Kt/V (Kt/V = dialysis adequacy)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">12</enrollment>
  <condition>Renal Failure</condition>
  <arm_group>
    <arm_group_label>2008 Sorbent system</arm_group_label>
    <description>Hemodialysis with the 2008 Sorbent system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2008 Sorbent System</intervention_name>
    <description>2008 Sorbent System with dialysate flow rates (Qd) of 400 and 500 ml/min while maintaining a constant blood flow rate (Qb) and constant dialyzer (KoA).</description>
    <arm_group_label>2008 Sorbent system</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        End-stage renal disease patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age &lt;/=18 years&#xD;
&#xD;
          -  end-stage renal disease (ESRD) patient on chronic high-flux hemodialysis for &lt;/= 6&#xD;
             months at time of enrollment&#xD;
&#xD;
          -  well-functioning fistula, graft or catheter as hemodialysis access, achieving blood&#xD;
             flow rates of &gt;/= 300 mL/min&#xD;
&#xD;
          -  ability to understand the English language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pre-dialysis serum blood urea nitrogen (BUN) concentration below 30 mg/dL in the last&#xD;
             three months&#xD;
&#xD;
          -  Severe Coronary Heart Disease or Heart Failure (New York Heart Association class IV)&#xD;
&#xD;
          -  Active Infections&#xD;
&#xD;
          -  Hepatitis B&#xD;
&#xD;
          -  Any other active infection that has required antibiotic treatment in the preceding&#xD;
             eight weeks&#xD;
&#xD;
          -  Pre-study lab values of any of the following (in the most recent routine lab work)&#xD;
&#xD;
          -  Sodium - Na+ &gt; 150 mmol/L, Na+ &lt; 132 mmol/L&#xD;
&#xD;
          -  Potassium - K+ &gt; 6.5 mmol/L, K+ &lt; 3.5 mmol/L&#xD;
&#xD;
          -  Total Calcium - Ca &gt; 12 mg/dL (3 mmol/L), total Ca &lt; 7.2 mg/dL (1.8 mmol/L)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>88 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Kotanko, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Renal Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yorkville Dialysis Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>September 19, 2011</study_first_submitted>
  <study_first_submitted_qc>September 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2011</study_first_posted>
  <last_update_submitted>April 10, 2017</last_update_submitted>
  <last_update_submitted_qc>April 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

